SE8601644D0 - ANTIBODY PREPARATION AGAINST CERTAIN DETERMINANTS IN HUMAN C3 AND ITS USE AND PREPARATION - Google Patents
ANTIBODY PREPARATION AGAINST CERTAIN DETERMINANTS IN HUMAN C3 AND ITS USE AND PREPARATIONInfo
- Publication number
- SE8601644D0 SE8601644D0 SE8601644A SE8601644A SE8601644D0 SE 8601644 D0 SE8601644 D0 SE 8601644D0 SE 8601644 A SE8601644 A SE 8601644A SE 8601644 A SE8601644 A SE 8601644A SE 8601644 D0 SE8601644 D0 SE 8601644D0
- Authority
- SE
- Sweden
- Prior art keywords
- preparation
- human
- against certain
- antibodies
- region
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Rheumatology (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Rehabilitation Therapy (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Antibody preparation directed against an individual neoantigen in the C3b region of human C3, and the use and production thereof. The preparation is characterized by immunnochemically reacting with (a) antigenic determinants in the C3b region of the alpha or beta chain of denatured human C3 in which the disulfide bonds have been reduced, but not with (b) human native C3. The use comprises immunochemically binding the preparation to C3 fragments, especially C3 fragments bound to immune complexes. The production encompasses the raising of an immune response containing the antibodies and selecting from said response the antibodies having the specificity given above.
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8601644A SE452065B (en) | 1986-04-11 | 1986-04-11 | ANTIBODY PREPARATION OUR ANTIBODIES ARE SPECIFIC TO DETERMINANTS IN THE C3 B REGION OF DENATURATED HUMAN C3 AND ITS USE AND MANUFACTURING |
AU72868/87A AU7286887A (en) | 1986-04-11 | 1987-03-19 | Antibody preparation directed against neoantigens in human c3 (complement factor 3) and the use and manufacture thereof |
JP50252087A JPS63503089A (en) | 1986-04-11 | 1987-03-19 | Antibody preparations and uses and production thereof against certain antigenic determinants in human C3 |
PCT/SE1987/000142 WO1987006344A1 (en) | 1986-04-11 | 1987-03-19 | Antibody preparation directed against neoantigens in human c3 (complement factor 3) and the use and manufacture thereof |
EP19870902799 EP0263161A1 (en) | 1986-04-11 | 1987-03-19 | Antibody preparation directed against neoantigens in human c3 (complement factor 3) and the use and manufacture thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8601644A SE452065B (en) | 1986-04-11 | 1986-04-11 | ANTIBODY PREPARATION OUR ANTIBODIES ARE SPECIFIC TO DETERMINANTS IN THE C3 B REGION OF DENATURATED HUMAN C3 AND ITS USE AND MANUFACTURING |
Publications (3)
Publication Number | Publication Date |
---|---|
SE8601644D0 true SE8601644D0 (en) | 1986-04-11 |
SE8601644L SE8601644L (en) | 1987-10-12 |
SE452065B SE452065B (en) | 1987-11-09 |
Family
ID=20364149
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8601644A SE452065B (en) | 1986-04-11 | 1986-04-11 | ANTIBODY PREPARATION OUR ANTIBODIES ARE SPECIFIC TO DETERMINANTS IN THE C3 B REGION OF DENATURATED HUMAN C3 AND ITS USE AND MANUFACTURING |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0263161A1 (en) |
JP (1) | JPS63503089A (en) |
AU (1) | AU7286887A (en) |
SE (1) | SE452065B (en) |
WO (1) | WO1987006344A1 (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6572856B1 (en) | 1998-09-10 | 2003-06-03 | The University Of Virginia Patent Foundation | Methods for the prevention and treatment of cancer using anti-C3b(i) antibodies |
CA2328356A1 (en) * | 1999-12-22 | 2001-06-22 | Itty Atcravi | Recreational vehicles |
AU2001234925A1 (en) * | 2000-02-08 | 2001-08-20 | The University Of Virginia Patent Foundation | Methods for the prevention and treatment of infections using anti-C3b(i) antibodies |
US20020160434A1 (en) * | 2001-04-30 | 2002-10-31 | George Jackowski | Biopolymer marker indicative of disease state having a molecular weight of 1777 daltons |
US6617308B2 (en) * | 2001-04-30 | 2003-09-09 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1865 daltons |
US7294688B2 (en) * | 2001-04-30 | 2007-11-13 | Nanogen Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1348 daltons |
US6593298B2 (en) * | 2001-04-30 | 2003-07-15 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1690 daltons |
US7049397B2 (en) * | 2001-04-30 | 2006-05-23 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1211 daltons |
US6602855B2 (en) * | 2001-04-30 | 2003-08-05 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1449 daltons |
US20040224423A1 (en) * | 2001-04-30 | 2004-11-11 | George Jackowski | Biopolymer marker indicative of disease state having a molecular weight of 2056 daltons |
US7314717B2 (en) | 2001-04-30 | 2008-01-01 | Nanogen Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1562 daltons |
US6756476B2 (en) * | 2001-04-30 | 2004-06-29 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 2021 daltons |
US6998243B2 (en) * | 2001-04-30 | 2006-02-14 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1793 daltons |
US20020160532A1 (en) * | 2001-04-30 | 2002-10-31 | George Jackowski | Biopolymer marker indicative of disease state having a molecular weight of 1998 daltons |
US20050255533A1 (en) * | 2004-02-10 | 2005-11-17 | Brendan Bioscience, Llc | Comprehensive food allergy test |
CL2008003241A1 (en) * | 2007-11-02 | 2009-07-31 | Novartis Ag | Binding molecule comprising an antigen-binding portion that binds to a c3b neoepitope; pharmaceutical composition comprising it; and its use to treat eye disorders |
US20100291106A1 (en) * | 2009-05-06 | 2010-11-18 | Novartis Ag | Compositions and methods for antibodies targeting complement protein c3b |
US20130084584A1 (en) * | 2010-03-31 | 2013-04-04 | Anna Blom | Method to detect tissue degradation leading to inflammation |
US9182396B2 (en) | 2010-11-02 | 2015-11-10 | Kypha, Inc. | Lateral flow immunoassay for complement activation and methods of use for point-of-care assessment of complement-associated disorders |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4342566A (en) * | 1980-02-22 | 1982-08-03 | Scripps Clinic & Research Foundation | Solid phase anti-C3 assay for detection of immune complexes |
GB2117514B (en) * | 1982-03-29 | 1985-08-29 | East Anglian Regional Health | Polyvalent antiglobulin reagent |
US4642284A (en) * | 1983-06-13 | 1987-02-10 | Scripps Clinic And Research Foundation | Method and system for detection of complement pathway activation |
-
1986
- 1986-04-11 SE SE8601644A patent/SE452065B/en not_active IP Right Cessation
-
1987
- 1987-03-19 WO PCT/SE1987/000142 patent/WO1987006344A1/en not_active Application Discontinuation
- 1987-03-19 AU AU72868/87A patent/AU7286887A/en not_active Abandoned
- 1987-03-19 JP JP50252087A patent/JPS63503089A/en active Pending
- 1987-03-19 EP EP19870902799 patent/EP0263161A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
AU7286887A (en) | 1987-11-09 |
WO1987006344A1 (en) | 1987-10-22 |
SE8601644L (en) | 1987-10-12 |
EP0263161A1 (en) | 1988-04-13 |
JPS63503089A (en) | 1988-11-10 |
SE452065B (en) | 1987-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE8601644D0 (en) | ANTIBODY PREPARATION AGAINST CERTAIN DETERMINANTS IN HUMAN C3 AND ITS USE AND PREPARATION | |
EP0597829A4 (en) | Novel monoclonal antibody to novel antigen associated with human tumors. | |
FI930580A (en) | TRI-OCH TETRAVALENSISM MONOPECIFIC ANTIGEN BINDANDE PROTEINER | |
DK0403156T3 (en) | Enhanced monoclonal antibodies to the human alpha / beta T cell receptor as well as its preparation and use | |
DE69229553T2 (en) | DETERMINATION OF COMPATIBILITY BY SOLUBLE HLA | |
AU612683B2 (en) | Synthetic peptides, antibodies directed against them, and the use thereof | |
DE3884646T2 (en) | Human carcinoma-associated antigen and antibodies binding to this antigen. | |
ATE119203T1 (en) | MONOCLONAL ANTIBODIES OF MOUSE AGAINST THE GP41 PROTEIN OF HUMAN IMMUNE DEFICIENCY SYNDROME VIRUS. | |
EP0460607A3 (en) | Novel monoclonal antibody to novel antigen associated with human tumors | |
ATE72400T1 (en) | CROSS-REACTIVE AND PROTECTIVE EPITOPES OF CIRCUMSPOROZOITE PROTEINS. | |
DE3854999T2 (en) | ANTIGENS AND ANTIBODIES ASSOCIATED WITH CARCINOMA RECOGNIZING THESE ANTIGENS | |
IT8026986A0 (en) | PURIFIED HUMAN PROSTATE ANTIGEN AND PROCEDURE FOR PREPARING ANTIBODY RELATED TO THIS ANTIGEN. | |
ATE4282T1 (en) | PROCESS FOR THE MANUFACTURE OF TOXOPLASM PREPARATIONS FOR TOXOPLASMOS DIAGNOSIS AND THE PREPARATIONS SO MADE. | |
NZ222006A (en) | Monoclonal antibodies specific to omega-ifn | |
DE3785795D1 (en) | MONOCLONAL ANTI-HUMAN CANCER ANTIBODIES. | |
DE3855280D1 (en) | ANTIGENT RECOGNIZED BY MCA 16-88 | |
DE3784364T2 (en) | TUMOR ASSOCIATED ANTIG. | |
ATE92081T1 (en) | TUMOR-ASSOCIATED ANTIGEN. | |
DE69111429T2 (en) | MONOCLONAL ANTIBODIES THAT MAKE A DIFFERENCE BETWEEN NATIVE PROTEINS AND PROTEINS WITH A MODIFIED SEQUENCE. | |
SE8604588D0 (en) | ANTIBODY PREPARATION TARGETED FOR PARATYREOIDA, ITS PREPARATION AND USE | |
DE376770T1 (en) | USE OF HUMAN IMMUNOGLOBULIN G OR FC FRAGMENTS, LIKE PREPARATORY MEDICINES FOR THE ADMINISTRATION OF MONOCLONAL ANTIBODIES TO HUMANS. | |
LV10202A (en) | An associate antigen of human carcinoma and its binding to an antibody | |
NO914094D0 (en) | NEW MONOCLONAL ANTIBODY AGAINST NEW ANTIGEN CONNECTED HUMAN TUMORS | |
NO900216D0 (en) | ANTI-IDIOTYPE ANTIBODY AGAINST ANTI-HUMAN MELANOMA-ASSOCIATED ANTIGEN WITH HIGH MOLECULE WEIGHT. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NUG | Patent has lapsed |
Ref document number: 8601644-1 Effective date: 19911108 Format of ref document f/p: F |